SEC 13F Intelligence

Deprince Race & Zollo Inc / DGX

Deprince Race & Zollo Inc’s Quest Diagnostics Inc Position

Does Deprince Race & Zollo Inc own Quest Diagnostics Inc (DGX)? Not currently — the last reported position was 110.2K shares worth $15M in Q2 2022; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$15M
Q2 2022
Shares
110.2K
% of Portfolio
+0.34%
Quarters Held
8
position exited

Position History DGX

Reported value by quarter
Q3 ’20: $15MQ3 ’20Q4 ’20: $17MQ4 ’20Q1 ’21: $29MQ1 ’21Q2 ’21: $31MQ2 ’21Q3 ’21: $32MQ3 ’21Q4 ’21: $32MQ4 ’21Q1 ’22: $25MQ1 ’22Q2 ’22: $15MQ2 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2022110.2K$15M+0.34%
Q1 2022185.4K$25M+0.49%
Q4 2021185.9K$32M+0.82%
Q3 2021217.9K$32M+0.85%
Q2 2021232.9K$31M+0.78%
Q1 2021226.1K$29M+0.78%
Q4 2020140.2K$17M+0.53%
Q3 2020127.2K$15M+0.55%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Deprince Race & Zollo Inc’s full portfolio or all institutional holders of DGX.